c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells

FASEB Journal

Volumn 13, Issue 14, 1999, Pages 1939-1949

  Brandt, Burkhard H ^a   Roetger, Antje ^a   Dittmar, Thomas ^b   Nikolai, Gerd ^b   Seeling, Matthes ^b   Merschjann, Anja ^a   Nofer, Jerzy Roch ^a   Dehmer Möller, Gunda ^a   Junker, Ralf ^a   Assmann, Gerd ^a   Zaenker, Kurt S ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Epidermal growth factor; F actin; Gelsolin; HUVEC

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; F ACTIN; GELSOLIN;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; CYTOSKELETON; DIMERIZATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; ONCOGENE C ERB; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0032730401     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.14.1939     Document Type: Article

References (42)

1. Schechter, A. L., Hung, M. C., Vaidyanathan, L., Weinberg, R. A., Yang-Feng, T. L., Francke, U., and Ullrich, A., and Coussens, L. (1985) The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229, 976-978
2. Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., Levinson, A., and Ullrich, A. (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with Neu oncogene Science 230, 1132-1139
3. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature (London) 319, 230-234
4. Bargmann, C. I., Hung, M. C., and Weinberg, R. A. (1986) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45, 649-657
5. Benz, C.C., Brandt, B. H., and Zanker, K. S. (1995) Gene diagnostics provide new insights into breast cancer prognosis and therapy. Gene 159, 3-7
6. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182
7. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., and Ullrich, A. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712
8. Press, M. F., Bernstein, L., Thomas, P. A., Meisner, L. F., Zhou, J. Y., Ma, Y., Hung, G., Robinson, R. A., Harris, C., El-Naggar, A., Slamon, D. J., Phillips, R. N., Ross, J. S., Wolman, S. R., and Flom, K. J. (1997) HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J. Clin. Oncol. 15, 2894-2904
9. Yu, D. H., and Hung, M. C. (1991) Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene 6, 1991-1996
10. Yu, D., and Hung, M.-C. (1995) The HER-2/neu gene in human cancers. In Molecular Basis of Oncology (Freireich, E. J., and Stass, S. A.. eds) pp. 131-162, Blackwell Science, Inc., Cambridge
11. Yu, D., Wang, S.-S., Dulski, K., Tsai, C.-M., Nicolson, G. L., and Hung, M.-C. (1994) c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res. 54, 3260, 3266
12. Graus-Porta, D., Beerli, R. R., Daly, J. M., and Hynes, N. E. (1997) ErbB-2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling. EMBO J. 16, 1647-1655
13. Murali, R., Breinin, P. J., Kiefer-Emmons, T., and Greene, M. I. (1996) Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains. Proc. Natl. Acad. Sci. USA 93, 6252-6257
14. Qian, X., levee, C. M., Freeman, J. K., Douglas, W. C., and Greene, M. I. (1994) Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. Proc. Natl. Acad. Sci. USA 91, 1500-4
15. Beerli, R. R., Graus-Porta, D., Woods-Cook, K., Chen, X., Yarden, Y., and Hynes, N. E. (1995) Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol. Cell. Biol. 15, 6496-6505
16. Graus-Porta, D., Beerli, R. R., and Hynes, N. E. (1995) Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol. Cell Biol. 15, 1182-1191
17. Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., Graus-Porta, D., Ratzkin, B. J., Seger, R., Hynes, N. E., and Yarden, Y. (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J. 15, 254-264
18. Cohen, B. D., Kiener, P. A., Green, J. M., Foy, L., Fell, H. P., and Zhang, K. (1996) The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J. Biol. Chem. 48, 30897-30903
19. Brandt B., Roetger, A., Heidl, S., Jackisch, C., Lellé, R. J., Assmann, G., and Zänker, K. S. (1998) Isolation of blood-borne epithelial-derived c-erbB-2 oncoprotein positive clustered cells from breast cancer patients peripheral blood. Int. J. Cancer 76, 824-828
20. Roetger A., Merschjann, A., Dittmar, T., Jackisch, C., Barnekow, A., and Brandt, B. (1998) Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model. Am. J. Pathol. 153, 1697-1806.
21. Janmey, P. A. (1994) Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly. Annu. Rev. Physiol. 56, 169-191
22. Cunningham, C. C., Stossel, T. P., and Kwiatkowski, D. J. (1991) Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science 251, 1233-1236
23. Billiah, M. M., and Lapetina, E. G. (1982) Rapid decrease of phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets, J. Biol. Chem. 257, 12705-12708
24. Welch, M. D., Mallavarapu, A., Rosenblatt, J., and Mitchison, T. J. Actin dynamics in vivo. Curr. Opin. Cell Biol. 9, 54-61, (1997)
25. Mitchison, T. J., and Cramer, L. P. (1996) Actin-based cell motility and cell locomotion. Cell 84, 371-379
26. DiGiovanna, M. P., and Stern, D. F. (1995) Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor. Cancer Res. 55, 1946-55
27. c-erbB-2: increased invasiveness may contribute to poor prognosis. Clin. Cancer Res. 3, 1629-1634
28. Tan, M., Yao, J., and Yu, D. (1997) Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res. 57, 1199-1205
29. Ben-Levy, R., Paterson, H. F., Mashall, C. J., and Yarden, Y. (1994) A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J. 13, 3302-3311
30. Ennis, B. W., Valverius, E. M., Bates, S. E., Lippman, M. E., Bellot, F., Kris, R., Schlessinger, J., Masui, H., Goldenberg, A., and Mendelsohn, J. (1989) Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. Mol. Endocrinol. 3, 1830-1838
31. Kraus, M. H., Popescu, N. C., Amsbaugh, S. C., and King, C. R. (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 6, 605-610
32. Marth, C., Lang, T., Cronauer, M. V., Doppler, W., Zeimet, A. G., Bachmair, F., Ullrich, A., and Daxenbichler, G. (1992) Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells. Int. J. Cancer 52, 311-316
33. King, C. R., Borrello, I., Bellot, F., Comoglio, P., and Schlessinger, J. (1988) EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J. 7, 1647-1651
34. Kornilova, E. S., Taverna, D., Hoeck, W., and Hynes, N. E. (1992) Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density. Oncogene 7, 511-519
35. Worthylake, R., and Wiley, H. S. (1997) Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu. J. Biol. Chem. 272, 8594-601
36. DiGiovanna, M. P., Lerman, M. A., Coffey, R. J., Muller, W. J., Cardiff, R. D., and Stern, D. F. (1998) Active signaling by Neu in transgenic mice. Oncogene 17, 1877-1884
37. Hynes, R. O., and Lander, A. D. (1992) Contact and adhesive specificities in the association, migration and targeting of cells and axons. Cell 68, 303-322
38. Stossel, T. P. (1993) On the crawling of animal cells. Science 260, 1086-1094
39. Button, E., Shapland, C., and Lawson, D. (1995) Actin, its associated proteins and metastasis. Cell Motil. Cytoskeleton 30, 247-251
40. Hartwig, J. H., Bokoch, G. M., Carpenter, C. L., Janmey, P. A., Taylor, L. A., Toker, A., and Stossel, T. P. (1995) Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 82, 643-653
41. Chen, P., Murphy-Ullrich, J. E., and Wells, A. (1996) A role of gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J. Cell Biol. 134, 689-698
42. Kwon, H. J., Yoshida, M., Nagaoka, R., Obinata, T., Beppu, T., and Horinouchi, S. (1997) Suppression of morphological transformation by radiciol is accompanied by enhanced gelsolin expression. Oncogene 15, 2625-2631